ZYDELIG NIRAPARIB 艾代拉里斯 思得适锭

Functions and indications:
1. Relapsed chronic lymphocytic leukemia. 2. Relapsed follicular B-cell non-Hodgkin’s lymphoma. 3. Relapsed small lymphocytic lymphoma.

Usage and dosage:
The dosage and dosage of different dosage forms and specifications of this product may vary. Please read the specific drug instructions for use, or follow the doctor’s advice. 1. The recommended dose is 150 mg, 2 times/day, swallow the whole tablet, whether taken with food or not. 2. If toxic reactions occur, the dose should be adjusted according to the table below

Adverse reactions:
1. Serious adverse reactions: including hepatotoxicity, severe diarrhea or colitis, pneumonia, intestinal perforation, severe skin reactions, hypersensitivity reactions, neutropenia. 2. Common adverse reactions: including nausea, vomiting, diarrhea, constipation, gastroesophageal reflux disease, headache, fever, chills, pneumonia, nasal mucosal congestion, rash, sepsis, bronchitis, sinusitis, urinary tract infection, joint pain. 3. Laboratory examinations often show decreased neutrophils, decreased platelets, decreased lymphocytes, increased AST and ALT, increased YGT, increased triglycerides, increased blood sugar, decreased blood sugar, and hyponatremia.

View details